United Therapeutics Corporation (UTHR)

515.46 -2.36% (-12.45)

Over 1M: -0.4%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

500 520 540
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 444.7M Q3 '21 — Operating Cash Flow: 185.6M Q3 '21 — Net Income: 162.7M Q4 '21 — Revenue: 415.2M Q4 '21 — Operating Cash Flow: 174.6M Q4 '21 — Net Income: 112.2M Q1 '22 — Revenue: 461.9M Q1 '22 — Operating Cash Flow: 288.7M Q1 '22 — Net Income: 239.9M Q2 '22 — Revenue: 466.9M Q2 '22 — Operating Cash Flow: 127M Q2 '22 — Net Income: 116M Q3 '22 — Revenue: 516M Q3 '22 — Operating Cash Flow: 258.6M Q3 '22 — Net Income: 239.3M Q4 '22 — Revenue: 491.5M Q4 '22 — Operating Cash Flow: 128.2M Q4 '22 — Net Income: 132.1M Q1 '23 — Revenue: 506.9M Q1 '23 — Operating Cash Flow: 374.8M Q1 '23 — Net Income: 240.9M Q2 '23 — Revenue: 596.5M Q2 '23 — Operating Cash Flow: 106.3M Q2 '23 — Net Income: 259.2M Q3 '23 — Revenue: 609.4M Q3 '23 — Operating Cash Flow: 346.2M Q3 '23 — Net Income: 267.6M Q4 '23 — Revenue: 614.7M Q4 '23 — Operating Cash Flow: 150.7M Q4 '23 — Net Income: 217.1M Q1 '24 — Revenue: 677.7M Q1 '24 — Operating Cash Flow: 376.5M Q1 '24 — Net Income: 306.6M Q2 '24 — Revenue: 714.9M Q2 '24 — Operating Cash Flow: 232.2M Q2 '24 — Net Income: 278.1M Q3 '24 — Revenue: 748.9M Q3 '24 — Operating Cash Flow: 377.2M Q3 '24 — Net Income: 309.1M Q4 '24 — Revenue: 735.9M Q4 '24 — Operating Cash Flow: 341.2M Q4 '24 — Net Income: 301.3M Q1 '25 — Revenue: 794.4M Q1 '25 — Operating Cash Flow: 461.2M Q1 '25 — Net Income: 322.2M Q2 '25 — Revenue: 798.6M Q2 '25 — Operating Cash Flow: 191.7M Q2 '25 — Net Income: 309.5M Q3 '25 — Revenue: 799.5M Q3 '25 — Operating Cash Flow: 562.1M Q3 '25 — Net Income: 338.7M Q4 '25 — Revenue: 790.2M Q4 '25 — Operating Cash Flow: 346.2M Q4 '25 — Net Income: 364.3M Q1 '26 — Revenue: 781.5M Q1 '26 — Operating Cash Flow: 463.3M Q1 '26 — Net Income: 274.9M Q2 '26 — Revenue: 783.3M Q2 '26 — Operating Cash Flow: 313.6M Q2 '26 — Net Income: 333M 0 200M 400M 600M 800M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

8.0
Oper. margin 44.4%
OE margin 29.7%
ROIC 29.6%
Accruals -5.2%
FCF margin 34.6%
Gross margin 86.1%
OCF margin 53.4%
ROA 18.2%
ROCE 21.2%
ROE 20.5%
OCF / EBIT 1.2×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

7.4
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.7
Interest cover 116.8×
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
F-score 7.9 pts
Payout 0.0%
Quick ratio 5.4×
Cash / Debt —
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.9
Sales CAGR 4Y +17.2%
Sales/sh Y/Y +3.8%
EPS CAGR 4Y +29.0%
EBIT CAGR +10.8%
EPS Y/Y +6.9%
EBIT Y/Y -3.2%
Sales Q/Q -1.9%
Div. growth —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.